A NXTAR gene-specific oligonucleotide led to the reduction in AR/AR-V7 and proliferation of PCa cells, while in a xenograft study, a small-molecule AR inhibitor restored NXTAR expression and blocked the tumor growth of enzalutamide-resistant PCa. This evidence concerns the gene AR and neoplasm.